The 12 Hallmarks of Ageing

Ageing in pets is driven by 12 biological hallmarks—not just time. Understanding these shared processes is transforming senior dog and cat care with new longevity-focused treatments.

At a Glance

Your senior dog or cat is not simply “getting old.” Inside their body, a set of twelve interconnected biological processes, collectively known as the hallmarks of ageing, are driving every age-related change you can see and many you cannot. These hallmarks explain why your pet develops joint stiffness, cognitive decline, cancer, kidney disease, and muscle loss as they age. They also explain why a Great Dane ages faster than a Chihuahua, why cats are uniquely vulnerable to chronic kidney disease, and why the old “multiply by seven” rule for calculating your dog’s age was never accurate.

The science of ageing, called geroscience, has moved from theory to clinical practice. Because these twelve hallmarks are shared across mammals, many of the most promising interventions were developed for humans and are now being studied in pets, while others are being developed in pets with direct relevance back to human medicine. Rapamycin, originally a human transplant drug, is now conditionally approved for feline heart disease and is in a major trial for dog longevity. Senolytic medicines (drugs that selectively clear damaged, non-functioning cells) were first developed in human oncology research and have now shown promising results for cognitive function in the first dog trial. NAD+ precursors, metformin, and various botanicals work through the same pathways in humans, dogs, and cats alike. The Dog Aging Project has enrolled over 50,000 companion dogs, and a company called Loyal is developing the first drugs specifically designed and FDA-tracked to extend canine lifespan. The broader truth is simple: when a treatment works on the hallmarks of ageing, it often works across species, because the underlying biology is the same.

This article is your map to what’s happening inside your ageing pet’s body — the understanding that makes every practical decision about their senior years make sense. The next articles in this series turn that understanding into action.

What Are the Hallmarks of Ageing?

Pet parents often ask: “Why do big dogs age faster?” or “Why do so many cats get kidney disease?” The answer to both questions lives in the same biological framework.

In 2013, a team of researchers led by Carlos López-Otín published a landmark paper in the journal Cell that identified nine fundamental processes driving ageing in all mammals. That paper has been cited over 20,000 times, making it one of the most influential biology papers of the twenty-first century. In 2023, the same team updated their framework, expanding it to twelve hallmarks by elevating three processes that had gained enough evidence to stand on their own: disabled macroautophagy (the cell’s recycling system), chronic inflammation, and dysbiosis (gut microbiome disruption).

What makes this framework revolutionary is its central insight: ageing is not one thing. It is twelve interconnected processes, each targetable, each measurable, and each — at least in principle — modifiable. A 2024 review in GeroScience systematically mapped every hallmark’s evidence base specifically in dogs. A 2022 paper in the American Journal of Veterinary Research did the same for both dogs and cats. The conclusion from both: every one of the twelve hallmarks has now been documented in companion animals. The biology of ageing in dogs mirrors the biology of ageing in cats and in humans. Your pet’s cells are ageing by the same rules yours are. That shared biology is precisely what makes companion animal research so valuable — and why understanding these hallmarks matters whether you share your home with a Labrador, a Golden Retriever, a Persian, or a British Shorthair.

The Three Tiers: Causes, Responses, and Consequences

Primary hallmarks (hallmarks 1 through 5) represent the root causes of cellular damage. These are the initial insults: DNA damage, telomere shortening, epigenetic drift, protein misfolding, and recycling failure — that accumulate over a lifetime. Think of these as the wear on your pet’s biological machinery.

Antagonistic hallmarks (hallmarks 6 through 8) are the body’s compensatory responses. Nutrient-sensing pathways, mitochondrial function, and cellular senescence all evolved to protect against damage. But over time, these protective mechanisms themselves become harmful. The security system starts causing more problems than the intruders — the very threats it was designed to stop.

Integrative hallmarks (hallmarks 9 through 12) are the organism-level consequences. When the primary damage and the broken responses cascade together, the result is stem cell exhaustion, disrupted cell-to-cell communication, chronic inflammation, and gut microbiome collapse. These are the hallmarks that produce the visible signs of ageing: the grey muzzle, the stiff joints, the slower mornings — the senior blood panel your vet flags.

No hallmark operates in isolation. Genomic instability feeds cellular senescence. Cellular senescence drives chronic inflammation. Chronic inflammation disrupts the gut microbiome. The gut microbiome influences nutrient sensing. Understanding this interconnection is the key to understanding why targeting ageing itself, rather than treating each disease separately, is the most promising direction in veterinary medicine today.

Hallmark 1: Genomic Instability

If your senior pet has been diagnosed with cancer, you have already seen this hallmark at work. It is the most visible consequence of a lifetime of DNA damage.

Every time a cell divides, it copies roughly 2.4 billion base pairs of DNA. Errors inevitably creep in. Oxidative stress from normal metabolism, environmental mutagens, and ultraviolet radiation compound the damage. Young cells repair most of this efficiently, but repair capacity declines with age. In dogs, that repair system was never as robust as in humans to begin with — and research has shown that dogs have lower base excision repair efficiency than humans, consistent with their shorter lifespans, and that they lose telomeric DNA roughly ten times faster.

The result is an extraordinarily high cancer burden. Cancer causes approximately 27% of deaths in purebred dogs in the UK, and up to 50% in some Scandinavian breed populations. Large and giant breeds carry a disproportionate share of that burden. A 2023 study analysing over 3,000 dogs found that median age at cancer diagnosis is inversely correlated with body weight. A 2024 analysis explained why: a multi-stage carcinogenesis model requiring approximately four driver mutations fits the breed data. Larger dogs have more cells — more mutational targets — and faster cell division rates, meaning more opportunities for errors at each cycle.

Breed-specific vulnerabilities make the pattern even clearer. Scottish Deerhounds carry heritable osteosarcoma susceptibility. Bernese Mountain Dogs are predisposed to histiocytic sarcoma through specific gene alterations. Flat-Coated Retrievers develop histiocytic sarcoma at uniquely high rates. The Dog Aging Project is now using advanced sequencing technology to measure rare somatic mutations in canine blood cells, aiming to predict lymphoma risk before clinical signs appear.

Cats develop cancer at lower overall rates than dogs, with lymphoma, mammary carcinoma, and squamous cell carcinoma predominating. Cancer in dogs remains one of the most active areas of veterinary research, yet feline-specific DNA repair data remains sparse, representing one of many areas where cat ageing biology needs more research attention. Understanding the distinct patterns of dog ageing and cat ageing is essential for tailoring preventive care.

Hallmark 2: Telomere Attrition

You have probably heard the phrase “biological clock.” Telomeres are one of the mechanisms that actually make it tick.

Telomeres are protective caps at the ends of chromosomes. Think of the plastic tips on shoelaces — without them, the lace frays. Each time a cell divides, its telomeres get slightly shorter. When they become critically short, the cell either stops dividing (entering senescence) or self-destructs through a process called apoptosis. This progressive shortening is one of the most fundamental timekeepers of ageing.

A pivotal 2012 study published in Cell Reports measured telomere length in blood cells across fifteen dog breeds and found a striking result: telomere length strongly predicted average breed lifespan. Small breeds maintain longer telomeres than large breeds, directly linking this hallmark to the size-lifespan paradox we explore later in this article. The mechanism is growth-driven — a Great Dane puppy undergoes vastly more cell divisions to reach adult size than a Chihuahua, eroding telomeres with each division. Researchers modelling telomere dynamics across 90 breeds confirmed that the birth-to-adult mass ratio is the key variable.

A 2025 study in Veterinary Sciences found that environmental stress further shortens canine telomeres, while male dogs paradoxically exhibit longer relative telomere lengths than females. This is opposite to the pattern seen in humans, where women typically have longer telomeres.

Cat-specific telomere data is extremely limited. However, cats’ longer average lifespans (12 to 18 years) and more uniform body sizes are consistent with slower telomere attrition. This is an area where feline ageing research lags significantly behind canine studies.

Hallmark 3: Epigenetic Alterations

This hallmark gave us the most powerful tool we have for measuring your pet’s biological age, and it debunked the “multiply by seven” rule once and for all.

Your pet’s DNA sequence does not change as they age. But the chemical tags that sit on top of that DNA, telling genes when to switch on and off — change dramatically. These tags are called epigenetic modifications, and the most studied type is DNA methylation. By measuring methylation at specific genomic sites, researchers can build epigenetic clocks that estimate biological age with remarkable accuracy. At least six major clock studies have been published for dogs since 2017.

The landmark finding came from the University of California, San Diego in 2020. Using 104 Labrador Retrievers, researchers showed that dog-to-human ageing follows a logarithmic, not linear, relationship. A one-year-old dog’s epigenome resembles a 30-year-old human’s — and a four-year-old dog matches a 52-year-old human. The relationship flattens with age. The “multiply by seven” rule was definitively debunked.

A 2022 study published in PNAS profiled 742 blood samples across 93 dog breeds and built four different clocks, including a dual-species human-dog clock with a correlation of R = 0.97. They identified individual DNA sites where methylation simultaneously correlated with increasing body weight and decreasing lifespan: molecular evidence for the size-lifespan trade-off — visible at the epigenetic level.

The Dog Aging Project’s 2024 analysis of 864 companion dogs delivered the most clinically actionable finding yet: each year of epigenetic age acceleration confers a 34% higher mortality risk. Giant breeds showed epigenomes averaging 0.37 years older per chronological year compared to the smallest breeds. This is the first large-scale demonstration that the rate of epigenetic ageing predicts individual mortality in dogs.

For cats, a 2021 study in GeroScience developed the first feline epigenetic clock, validated not only in domestic cats but also in cheetahs, tigers, and lions. A universal pan-mammalian clock, built from over 11,000 methylation arrays across 185 species, confirmed that ageing-related methylation changes are deeply conserved across all mammals.

The epigenetic clock story opens a remarkable possibility. In 2006, Japanese researcher Shinya Yamanaka identified four genes — now known as the Yamanaka factors (OCT4, SOX2, KLF4, and c-Myc) — that can reprogramme adult cells back to a stem-cell-like state, effectively resetting their epigenetic age. The discovery won him the 2012 Nobel Prize in Physiology or Medicine. More recently, researchers have shown that partial reprogramming using these factors extends lifespan and reverses signs of ageing in mice. A 2016 study in Cell was the first to demonstrate this in living animals. A 2022 study in Nature Aging extended the finding, showing measurable reversal of age-associated molecular changes during normal physiological ageing. The implication is profound: if epigenetic ageing is reversible in a petri dish and in a mouse, it may one day be partially reversible in a living dog or cat. This is emerging science, not yet a clinical tool, and applications in companion animals remain years away. But it reframes what the hallmarks represent: not just damage that accumulates, but damage that the body retains the instructions to undo.

Hallmark 4: Loss of Proteostasis

If your senior dog has started staring at walls, getting lost in familiar rooms, or pacing at night, you may be seeing this hallmark in action. It is the same biology that drives Alzheimer’s disease in humans.

Proteostasis, the maintenance of protein quality, depends on a network of molecular chaperones, the ubiquitin-proteasome system, and autophagy. When this network fails, damaged and misfolded proteins accumulate. The most dramatic manifestation in pets is Canine Cognitive Dysfunction (CCD), the veterinary analogue of Alzheimer’s disease — and one of the most heartbreaking diagnoses a pet parent can receive.

Dogs spontaneously accumulate β-amyloid plaques with age, and the canine Aβ peptide shares 100% sequence identity with the human version — meaning the same protein that accumulates in human Alzheimer’s patients accumulates in ageing dogs. Diffuse plaques appear in the prefrontal cortex, hippocampus, and cerebral vasculature. The Dog Aging Project found that CCD odds increase 52% with each additional year of age and are 6.47 times higher in inactive versus very active dogs. Clinical signs follow the DISHAA framework: Disorientation, Interaction changes, Sleep-wake disruption, House-soiling, Activity changes, and Anxiety. CCD may affect over 22% of geriatric dogs.

Cats may be an even better model for Alzheimer’s research because they spontaneously develop both β-amyloid and tau pathology. In the largest feline brain autopsy study, 27 of 32 cats showed amyloid staining, and 4 of 32 had tau-positive tangles resembling early stages of human Alzheimer’s. A 2025 study in the European Journal of Neuroscience showed that amyloid pathology increases synaptic engulfment by immune cells in feline brains, a mechanism mirroring human Alzheimer’s. Very few non-primate species exhibit both amyloid and tau pathology, placing cats in a unique position for translational neuroscience.

Interventions targeting proteostasis in dogs include antioxidant-enriched diets with mitochondrial cofactors (lipoic acid, L-carnitine), medium-chain triglycerides providing ketone fuel to bypass metabolic impairment, SAMe, and selegiline (approved by the US FDA’s Center for Veterinary Medicine for CCD).

Hallmark 5: Disabled Macroautophagy

Think of your pet’s cells as having an internal waste management service. When that service breaks down, debris accumulates and cellular function deteriorates.

Macroautophagy, literally “self-eating,” is the cell’s primary recycling machinery for clearing damaged organelles and protein aggregates. With age, this system slows — and the result is an accumulation of cellular debris: lipofuscin deposits in ageing neurons, β-amyloid buildup in the brain, and lysosomal dysfunction across multiple tissues. Natural canine models of lysosomal storage disorders, such as neuronal ceroid lipofuscinosis in Dachshunds, demonstrate what happens when this pathway fails catastrophically.

Rapamycin is the primary intervention targeting this hallmark. By inhibiting a molecular pathway called mTOR, rapamycin de-represses autophagy and promotes cellular recycling. The first randomised controlled trial in companion dogs, published in GeroScience in 2017, treated 24 middle-aged dogs for ten weeks and demonstrated improved heart function, consistent with enhanced autophagy in heart muscle cells. Owners reported increased activity levels. No significant clinical side effects were observed — a crucial finding for a drug intended for long-term use.

The rapamycin story extends to cats with a remarkable clinical development. A trial demonstrated that weekly delayed-release rapamycin halted the progression of left ventricular hypertrophy in cats with subclinical hypertrophic cardiomyopathy (HCM), the most common heart disease in cats. This led to conditional approval of rapamycin for feline HCM by the US FDA’s Center for Veterinary Medicine in early 2025, the first mTOR inhibitor approved for a cardiac condition in any companion animal. We will explore rapamycin’s broader implications in depth in a dedicated article.

Hallmark 6: Deregulated Nutrient Sensing

This hallmark sits at the heart of the most remarkable natural experiment in ageing biology: why a Great Dane lives 7 years while a Chihuahua lives 16.

Within a single species, domestic dogs exhibit a nearly 100-fold variation in body size and an approximately two-fold variation in lifespan. The driving force behind both is the insulin/IGF-1 signalling axis, one of the most conserved nutrient-sensing pathways in biology — active in everything from worms to humans.

A 2007 study published in Science identified a single IGF1 gene variant present in virtually all small breeds and absent from giant breeds. Large dogs have circulating IGF-1 levels up to 28 times higher than small dogs. A landmark analysis of 56,000 dogs across 74 breeds demonstrated that large dogs do not simply die of different diseases. They age faster at a fundamental biological level. Every 2 kilograms of body mass reduces lifespan by approximately one month. The driving force is an accelerated rate of ageing, not earlier onset of senescence.

The practical proof that modulating nutrient sensing extends canine lifespan came from the Purina Life Span Study, a 14-year investigation following 48 Labrador Retrievers. Dogs fed 25% fewer calories lived 1.8 years longer (median 13.0 versus 11.2 years), a 15% lifespan extension — the equivalent of more than a decade in human terms. Calorie-restricted dogs showed delayed onset of chronic disease by two years, later osteoarthritis, lower insulin resistance, and reduced body fat. Increasing insulin resistance independently predicted shorter lifespan and earlier disease onset.

Cats face their own metabolic ageing challenges. As obligate carnivores with unique glucose metabolism, approximately 90% of feline diabetes is type 2, closely resembling human type 2 diabetes in its association with obesity, insulin resistance, and islet amyloidosis. This last pathology — islet amyloidosis — is shared only by humans, macaques, and cats, making felines an important comparative model for metabolic ageing.

Hallmark 7: Mitochondrial Dysfunction

When your senior pet seems to tire more easily, sleep more, or lose interest in activities they once loved, failing mitochondria may be part of the story.

Mitochondria are the energy-producing structures inside every cell. With age, their electron transport chains leak more reactive oxygen species (ROS), ATP production declines — and oxidative damage accumulates. Research in aged Beagles has shown that isolated mitochondria from senior dogs produce significantly more ROS than those from younger animals. Oxidative damage markers (protein carbonyls, 8-OHdG, malondialdehyde) accumulate progressively in ageing dog brains.

Breed size matters here too. A 2018 study using metabolic profiling showed that large-breed old dogs accumulate more oxidative DNA damage and maintain a persistent glycolytic metabolic profile, suggesting their mitochondria are less efficient and forcing cells to rely on a less productive backup energy pathway — glycolysis. Follow-up research confirmed that regardless of size, older dogs show depleted glutathione (a key antioxidant) and reduced ATP, but large old dogs have a specific defect at the pyruvate kinase step in glycolysis.

A landmark University of California, Irvine study in aged Beagles — published by Cotman and colleagues in 2002 — showed that diets enriched with vitamins E and C, fruits, vegetables, lipoic acid, and L-carnitine significantly improved cognitive function, consistent with supporting mitochondrial health. In cats, a 2024 study in the British Journal of Nutrition showed that glycine supplementation partially restores glutathione deficiency in ageing cats, addressing one of the downstream consequences of mitochondrial dysfunction.

A notable research gap exists: no direct measurements of mitochondrial DNA mutation accumulation during ageing have been published in the canine literature. This is a fundamental measurement in human and rodent geroscience that has simply not been done in dogs.

Hallmark 8: Cellular Senescence

Your pet’s body has cells that have stopped working but will not go away, and they are actively making their neighbours sick.

Cellular senescence is a state of permanent growth arrest. Senescent cells stop dividing but resist the normal cell death signals that should clear them. Worse, they release a cocktail of inflammatory molecules called the Senescence-Associated Secretory Phenotype (SASP), which damages surrounding tissue, recruits immune cells, and can even induce senescence in neighbouring cells. They are sometimes called “zombie cells”: not alive in any useful sense, not dead either — and harmful to everything around them.

Age-dependent increases in senescence markers have been directly measured in canine tissues. A study published in Veterinary Pathology demonstrated a four-fold increase in senescent fibroblasts and an eight-fold increase in senescent Leydig cells in old versus young dogs. A 2025 multi-omics study identified nine ageing-related cell populations and validated metabolic markers of senescence in canine tissues.

The first randomised controlled trial of senolytic drugs in companion dogs was published in 2024 in Scientific Reports. Seventy senior dogs with mild-to-moderate cognitive impairment received either placebo or a combination of a NAD+ precursor (given daily) and a senolytic compound (given on two consecutive days monthly). At three months: significant improvement in cognitive scores, with 88.9% of full-dose dogs showing improvement versus 60% on placebo. No significant adverse effects were reported. This is currently the only published senolytic trial in companion animals.

In cats, the senescence story connects directly to the most prevalent feline ageing disease. A study published in Veterinary Sciences found that cats with chronic kidney disease (CKD) had significantly increased p16 expression, a key senescence marker, in their kidneys. Critically, p16 also correlated with age even in cats without CKD, suggesting that senescence-driven kidney ageing may underlie both normal feline renal decline and CKD progression. This insight could transform how we think about feline kidney disease: not as a discrete illness but as an ageing process — one that senolytic drugs might one day slow.

Hallmark 9: Stem Cell Exhaustion

That slower recovery from injuries, the thinning coat, the muscle loss your vet calls “sarcopenia”: all of these reflect your pet’s declining pool of stem cells — the body’s repair and renewal workforce.

Stem cells are the body’s repair and renewal system. With age, they divide less frequently, differentiate less effectively, and eventually deplete. Mesenchymal stem cells from young donor dogs proliferate 2.4 times faster with superior differentiation potential compared to cells from aged dogs. Bone marrow composition gradually shifts from red (blood-producing) to yellow (fat-filled) marrow, reducing the body’s capacity to generate new blood cells — and to mount robust immune responses.

Breed differences in stem cell ageing are significant. Research has shown that stem cells from German Shepherds, Labradors, and Golden Retrievers undergo senescence faster than those from Border Collies, Malinois, and Hovawarts, potentially contributing to breed-specific lifespan differences. A 2025 study in Communications Biology identified 17 transcriptional and 5 metabolic markers of canine stem cell ageing, and demonstrated that overexpression of a specific enzyme (NMNAT1) can delay or reverse ageing in dog stem cells.

Sarcopenia, the age-related loss of lean body mass, is where stem cell exhaustion becomes clinically visible. In cats, sarcopenia is particularly significant: 15% of cats over 12 are underweight, and cats over 14 are 15 times more likely to be underweight than younger cats. Senior cats may require up to 50% more dietary protein per kilogram than younger cats to maintain muscle mass, making nutritional management critical.

Hallmark 10: Altered Intercellular Communication

Ageing does not just affect individual cells. It disrupts how cells talk to each other, cascading dysfunction across entire organ systems.

Your pet’s body relies on an intricate communication network of hormones, growth factors, inflammatory signals, and neurotransmitters to coordinate everything from immune responses to tissue repair. With age, these signals become dysregulated. In dogs, IGF-1 levels decline across all groups, but the pattern differs between sexes and sizes. Serum angiotensin II and endothelin-1, markers of vascular signalling, are significantly elevated in old companion dogs compared to young ones, indicating deregulated blood vessel communication — a shift with implications for heart and kidney health.

In the ageing brain, activated immune cells called astrocytes and microglia shift from protective to pro-inflammatory, releasing mediators that damage surrounding neurons. This neuroinflammation is a key driver of cognitive decline in both dogs and cats. The SASP from senescent cells (Hallmark 8) constitutes perhaps the most pathological form of altered communication, creating a “contagious ageing” effect where damaged cells spread dysfunction to their neighbours through inflammatory signalling.

In cats, a 2025 study published in Frontiers in Aging Neuroscience found that the ratio of pro-inflammatory to anti-inflammatory signalling molecules (specifically IL-1β and IL-10) predicts cognitive and behavioural changes in clinically healthy senior cats aged 7 to 16. This means that communication disruption precedes visible disease, potentially offering an early warning window — and a reason to test before symptoms appear.

Research into mesenchymal stem cell-derived extracellular vesicles (tiny packets of signalling molecules released by stem cells) shows anti-inflammatory effects on microglial cells, offering a potential therapeutic approach to restoring healthy intercellular communication in ageing pets.

Hallmark 11: Chronic Inflammation

Veterinarians and researchers call it “inflammaging”: a low-grade, persistent inflammation that quietly drives nearly every age-related disease your pet will face.

Chronic inflammation is increasingly recognised as the hallmark that links all the others to clinical disease. Unlike the acute inflammation that helps heal a wound or fight an infection, inflammaging is sterile (no pathogen involved), low-grade (often undetectable on routine blood work) — and persistent. It creates a tissue environment that promotes cancer, accelerates cognitive decline, worsens joint disease, and damages kidneys.

The most rigorous canine inflammaging study followed 80 Labrador Retrievers longitudinally. Serum oxidative DNA damage markers increased significantly with age, while heat shock protein 70, a key cellular stress response molecule, decreased. This pattern shows the double burden of inflammaging: rising damage alongside declining protective capacity — a biological double burden.

A 2023 study in Biogerontology measured key inflammatory cytokines (IL-6, IL-1β, and TNF-α) across healthy dogs of different sizes and ages, finding that IL-6 follows a U-shaped trajectory: decreasing in young dogs, then rising progressively through the senior and geriatric years, mirroring the human inflammaging pattern. Intriguingly, sterilised dogs had higher IL-1β levels, and intact females had the lowest, suggesting sex hormones may offer some protection against inflammaging.

In cats, research has shown a similar U-shaped pattern for pro-inflammatory cytokines, with levels declining from early adulthood and then progressively increasing in older cats. Anti-inflammatory IL-10 tends to decline with age, potentially removing a natural brake on inflammation. A 2025 review identified serum amyloid A (SAA) as a promising early diagnostic marker for feline inflammaging, noting that aged obese cats show enlarged fat cells with immune cell infiltration, turning their fat tissue into an active source of inflammatory signals.

Hallmark 12: Dysbiosis

Your pet’s gut microbiome, the trillions of bacteria living in their digestive tract, does not just affect digestion. It shapes immunity, inflammation, brain function — and even how fast they age.

The gut microbiome changes substantially with age in both dogs and cats. A 2023 study of 106 dogs found that senior dogs had higher levels of certain bacterial groups associated with inflammation, reduced butyrate-producing capacity (butyrate is a key fuel for gut lining cells), and lower concentrations of beneficial short-chain fatty acids. A validated diagnostic tool called the Dysbiosis Index, developed at Texas A&M University, can now track microbiome health over time by measuring seven key bacterial groups.

The gut-brain connection is particularly striking. The first study linking gut microbiome composition to cognitive performance in dogs found that higher age correlated with lower Fusobacteria, and dogs with better memory scores had distinct microbiome profiles, paralleling findings in humans with Alzheimer’s disease. Loss of key species including Peptacetobacter hiranonis (the primary converter of primary to secondary bile acids) and Faecalibacterium prausnitzii (a butyrate-producing anti-inflammatory species) are hallmarks of canine dysbiosis.

In cats, a five-year longitudinal study showed that over half of observed bacterial groups changed between kitten and adult ages, with beneficial Bifidobacterium declining or disappearing entirely. Cats with chronic kidney disease show significantly decreased microbial richness and increased production of uraemic toxins, linking dysbiosis directly to the most prevalent feline ageing disease — chronic kidney disease. Research has shown that targeted dietary interventions can increase beneficial bacteria and butyric acid production while decreasing uraemic toxins in senior cats.

Interventions under investigation include multi-strain probiotics (with elderly dogs showing the greatest benefit from supplementation), fecal microbiota transplant for refractory gastrointestinal disease, and prebiotic/postbiotic combinations that modulate senior dog microbiota toward greater short-chain fatty acid production.

The Size-Lifespan Paradox: Why Big Dogs Age Faster

It is the most counterintuitive fact in biology: within nearly every other species, larger individuals live longer. In dogs, the opposite is true — and the hallmarks framework explains why.

Across the animal kingdom, elephants outlive mice and whales outlive rabbits. But within the domestic dog, a 70-kilogram Great Dane lives roughly 7 years while a 3-kilogram Chihuahua lives 16. The hallmarks framework reveals that this is not about one mechanism. It is about several hallmarks accelerating simultaneously in larger breeds.

Telomere attrition (Hallmark 2): Large breeds undergo more cell divisions during growth, shortening telomeres faster. Epigenetic ageing (Hallmark 3): Giant breeds show epigenomes averaging 0.37 years older per chronological year. Nutrient sensing (Hallmark 6): Large breeds have IGF-1 levels up to 28 times higher, driving faster growth but accelerating ageing. Mitochondrial dysfunction (Hallmark 7): Large-breed old dogs show more oxidative DNA damage and less efficient cellular metabolism. Genomic instability (Hallmark 1): More cells and faster division rates mean more opportunities for cancer-causing mutations.

The convergence is clear: large dogs do not just get sick earlier. They accumulate hallmark damage faster across multiple pathways simultaneously. Understanding this pattern has direct implications for how we approach senior care. A seven-year-old Golden Retriever is not biologically equivalent to a seven-year-old Pomeranian, and their wellness plans should reflect that difference.

Cats, with their relatively uniform body sizes (most domestic cats weigh 3 to 6 kilograms), largely sidestep this paradox. Their ageing challenges are driven more by organ-specific vulnerabilities in the kidneys, thyroid, and heart than by the systemic acceleration seen in large-breed dogs. This makes feline ageing a complementary rather than parallel story to canine ageing, and understanding both gives pet parents the most complete picture of how their companion’s body changes with time.

Why Your Pet Matters to Human Medicine

The science of ageing in companion animals is not just about helping pets live longer. It is generating insights that could transform human medicine.

Dogs occupy a unique position in ageing research. They share our homes, breathe our air, eat processed food, experience our pollutants, and develop the same age-related diseases we do: cancer, cognitive decline, heart disease, kidney failure, diabetes. A 2018 study comparing mortality patterns across 112,000 humans and 74,000 dogs found remarkably similar age trajectories for multiple disease categories.

The Dog Aging Project, founded in 2014 and funded by the United States National Institute on Aging, has enrolled over 50,000 companion dogs across the country. Its aims span four areas: characterising ageing through comorbidity patterns, identifying genetic determinants through whole-genome sequencing, mapping environmental and lifestyle risk factors, and testing rapamycin via the TRIAD study (Test of Rapamycin In Aging Dogs). The TRIAD trial targets approximately 580 dogs receiving rapamycin or placebo once weekly for one year with two years of follow-up. Its design paper describes it as the first rigorous test of a pharmacological intervention against biological ageing with lifespan and healthspan as endpoints, performed outside of the laboratory, in any species. Results are expected around 2029.

Dogs’ compressed lifespans (10 to 15 years versus 70+ for humans) accelerate research timelines five- to eight-fold. Their extraordinary genetic diversity, with breed lifespans ranging from 5.5 to 14.5 years, creates a natural experiment in ageing genetics — the closest thing biology has to a controlled laboratory study performed at species scale. And the conserved epigenetic ageing framework (dual-species clocks with R = 0.97) means anti-ageing interventions validated in dogs can be directly translated to humans using the same mathematical models.

Research from the Dog Aging Project has also revealed something profound about the social dimension of ageing: social support was five times more predictive of dog health and mobility than financial factors. Dogs living in households with strong social connections and stable environments aged better, paralleling human social determinants of health. When we learn how to help our pets age well, we learn something about how to help ourselves age well too.

What Comes Next: From Understanding to Action

This article has mapped the biological terrain of ageing in your pet. The twelve hallmarks are not abstract science. They are the mechanisms behind the grey muzzle, the stiff morning walk, the afternoon nap that stretches a little longer each year, the blood panel that starts showing changes. Understanding what is happening inside your pet’s body is the first step. The next step is doing something about it — and that is where our story goes next.

Our upcoming articles will move from understanding to action. NAD+ and Cellular Energy will explore how your pet’s cells produce energy, what goes wrong with age, and the evidence behind compounds being studied to support that system — from NAD+ precursors (NMN and NR) and mitochondrial cofactors (CoQ10, L-Carnitine, alpha-lipoic acid) to emerging interventions like Urolithin A, spermidine, and astaxanthin. Rapamycin and Autophagy will tell the full story of the most promising longevity drug in veterinary medicine, from its accidental discovery on Easter Island to conditional approval for feline heart disease. Light and Field Therapies will cover photobiomodulation, pulsed electromagnetic field therapy, and other non-invasive approaches targeting multiple hallmarks simultaneously.

The science of ageing is moving fast. What was theoretical five years ago is now in clinical trials with thousands of dogs. What was impossible ten years ago is now conditionally approved for cats. Your pet’s golden years do not have to mean a slow decline. They can mean a longer, healthier, more vibrant life — and that possibility starts with understanding what is happening inside their body right now.

Sources Cited in This Article

1. López-Otín, C., Blasco, M.A., Partridge, L., Serrano, M., & Kroemer, G. (2023). Hallmarks of aging: An expanding universe. Cell, 186(2), 243–278. https://doi.org/10.1016/j.cell.2022.11.001

2. López-Otín, C., Blasco, M.A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The Hallmarks of Aging. Cell, 153(6), 1194–1217. https://doi.org/10.1016/j.cell.2013.05.039

3. Jiménez, A.G. (2024). A revisiting of “the hallmarks of aging” in domestic dogs: current status of the literature. GeroScience, 46, 1663–1680. https://doi.org/10.1007/s11357-023-00911-5

4. McKnight, D., et al. (2022). Comparative veterinary geroscience. American Journal of Veterinary Research, 83(6). https://doi.org/10.2460/ajvr.22.02.0027

5. Creevy, K.E., et al. (2022). An open science study of ageing in companion dogs. Nature, 602, 51–57. https://doi.org/10.1038/s41586-021-04282-9

6. Fick, L.J., et al. (2012). Telomere Length Correlates with Life Span of Dog Breeds. Cell Reports, 2(6), 1530–1536. https://doi.org/10.1016/j.celrep.2012.11.021

7. Wang, T., et al. (2020). Quantitative Translation of Dog-to-Human Aging by Conserved Remodeling of the DNA Methylome. Cell Systems, 11(2), 176–185. https://doi.org/10.1016/j.cels.2020.06.006

8. Horvath, S., et al. (2022). DNA methylation clocks for dogs and humans. PNAS, 119(21), e2120887119. https://doi.org/10.1073/pnas.2120887119

9. Raj, K., et al. (2021). Epigenetic clock and methylation studies in cats. GeroScience, 43, 2363–2378. https://doi.org/10.1007/s11357-021-00445-8

10. Lu, A.T., et al. (2023). Universal DNA methylation age across mammalian tissues. Nature Aging, 3, 1144–1166. https://doi.org/10.1038/s43587-023-00462-6

11. Dog Aging Project (2024). Aging at scale: Younger dogs and larger breeds show accelerated epigenetic aging. bioRxiv. https://doi.org/10.1101/2024.10.03.616519

12. Thompson, M.J., et al. (2017). An epigenetic aging clock for dogs and wolves. Aging, 9(3), 1055–1068. https://doi.org/10.18632/aging.101211

13. Greer, K.A., et al. (2022). Evaluation of cognitive function in the Dog Aging Project. Scientific Reports, 12, 13242. https://doi.org/10.1038/s41598-022-15837-9

14. McGeachan, R.I., et al. (2025). Amyloid-beta pathology increases synaptic engulfment by glia in feline cognitive dysfunction syndrome. European Journal of Neuroscience. https://doi.org/10.1111/ejn.70180

15. Fiock, K.J., et al. (2020). β-amyloid and Tau Pathology in the Aging Feline Brain. Journal of Comparative Neurology, 528(1), 108–121. https://doi.org/10.1002/cne.24741

16. Urfer, S.R., et al. (2017). A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs. GeroScience, 39(2), 117–127. https://doi.org/10.1007/s11357-017-9972-z

17. Coleman, L.G., et al. (2025). TRIAD study design and rationale. GeroScience, 47, 2851–2877. https://doi.org/10.1007/s11357-024-01484-7

18. Sutter, N.B., et al. (2007). A single IGF1 allele is a major determinant of small size in dogs. Science, 316(5821), 112–115. https://doi.org/10.1126/science.1137045

19. Kraus, C., Pavard, S., & Promislow, D.E.L. (2013). The size-life span trade-off decomposed: why large dogs die young. The American Naturalist, 181(4), 492–505. https://doi.org/10.1086/669665

20. Kealy, R.D., et al. (2002). Effects of diet restriction on life span and age-related changes in dogs. JAVMA, 220(9), 1315–1320. https://doi.org/10.2460/javma.2002.220.1315

21. Lawler, D.F., et al. (2008). Diet restriction and ageing in the dog: major observations over two decades. British Journal of Nutrition, 99(4), 793–805. https://doi.org/10.1017/S0007114507871686

22. Simon, A.K., et al. (2024). Improved owner-assessed cognitive function in senior dogs receiving a senolytic and NAD+ precursor combination. Scientific Reports, 14, 14364. https://doi.org/10.1038/s41598-024-63031-w

23. Quimby, J.M., et al. (2021). Renal Senescence, Telomere Shortening and Nitrosative Stress in Feline CKD. Veterinary Sciences, 8(12), 314. https://doi.org/10.3390/vetsci8120314

24. Merz, S.E., et al. (2019). Aging and Senescence in Canine Testes. Veterinary Pathology, 56(5), 715–724. https://doi.org/10.1177/0300985819843452

25. Chen, X., et al. (2025). Multi-omics analysis of canine aging markers and evaluation of stem cell intervention. Communications Biology, 8, 256. https://doi.org/10.1038/s42003-025-08333-z

26. Shi, B., et al. (2020). Birth mass is the key to understanding the negative correlation between lifespan and body size in dogs. Aging, 12(7), 5910–5921. https://doi.org/10.18632/aging.101081

27. Jiménez, A.G., et al. (2018). Cellular metabolism and oxidative stress in small and large breed dogs. PLOS ONE, 13(4), e0195832. https://doi.org/10.1371/journal.pone.0195832

28. Alexander, J.E., et al. (2018). Understanding How Dogs Age: Longitudinal Analysis of Markers of Inflammation, Immune Function, and Oxidative Stress. Journals of Gerontology A, 73(6), 720–728. https://doi.org/10.1093/gerona/glx182

29. Sánchez-Suárez, J., et al. (2023). Inflammaging in domestic dogs: basal level concentrations of IL-6, IL-1β, and TNF-α. Biogerontology, 24, 747–759. https://doi.org/10.1007/s10522-023-10037-y

30. McKenzie, B.A. (2025). Immunosenescence and Inflammaging in Dogs and Cats: A Narrative Review. JVIM. https://doi.org/10.1111/jvim.70159

31. Kipar, A., et al. (2005). Age-related dynamics of constitutive cytokine transcription levels of feline monocytes. Experimental Gerontology, 40(8–9), 620–626. https://doi.org/10.1016/j.exger.2005.06.001

32. Fernández-Pinteño, A., et al. (2023). Age-associated changes in intestinal health biomarkers in dogs. Frontiers in Veterinary Science, 10, 1213287. https://doi.org/10.3389/fvets.2023.1213287

33. Kubinyi, E., et al. (2020). Gut Microbiome Composition is Associated with Age and Memory Performance in Pet Dogs. Animals, 10(9), 1505. https://doi.org/10.3390/ani10091505

34. Bermingham, E.N., et al. (2018). Key bacterial families related to digestion of protein and energy in dogs. PeerJ, 6, e3019. https://doi.org/10.7717/peerj.3019

35. Rafalko, J.M., et al. (2023). Age at cancer diagnosis by breed, weight, sex, and cancer type. PLOS ONE, 18(2), e0280401. https://doi.org/10.1371/journal.pone.0280401

36. Bodyfield, C.F., et al. (2024). The effect of body size and inbreeding on cancer mortality in breeds of the domestic dog. Royal Society Open Science, 11(1), 231429. https://doi.org/10.1098/rsos.231429

37. Hoffman, J.M., et al. (2018). Reproductive capability is associated with lifespan and cause of death in companion dogs. PLOS ONE, 13(8), e0198794. https://doi.org/10.1371/journal.pone.0198794

38. Williams, K., et al. (2024). The potential for senotherapy as a novel approach to extend life quality in veterinary medicine. Frontiers in Veterinary Science, 11, 1369153. https://doi.org/10.3389/fvets.2024.1369153

39. Loyal for Dogs. (2025). FDA CVM accepts Reasonable Expectation of Effectiveness for LOY-002 for senior dog lifespan extension. https://loyal.com/posts/loy-002-receives-rxe-from-the-fda

40. Loyal for Dogs. (2023). FDA CVM agrees data supports Reasonable Expectation of Effectiveness for LOY-001 for large dog lifespan extension. https://loyal.com/posts/loyal-announces-historic-fda-milestone-for-large-dog-lifespan-extension-drug

41. Greer, K.A., Canterberry, S.C., & Murphy, K.E. (2011). Connecting serum IGF-1, body size, and age in the domestic dog. AGE, 33(3), 475–483. https://doi.org/10.1007/s11357-010-9182-4

42. Yamanaka, S., & Takahashi, K. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663–676. https://doi.org/10.1016/j.cell.2006.07.024

43. Ocampo, A., et al. (2016). In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. Cell, 167(7), 1719–1733. https://doi.org/10.1016/j.cell.2016.11.052

44. Browder, K.C., et al. (2022). In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice. Nature Aging, 2, 243–253. https://doi.org/10.1038/s43587-022-00183-2

45. Cotman, C.W., et al. (2002). Brain aging in the canine: a diet enriched in antioxidants reduces cognitive dysfunction. Neurobiology of Aging, 23(5), 809–818. https://doi.org/10.1016/S0197-4580(02)00073-8